• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Neuromodulation for Treatment-Refractory PTSD.用于治疗难治性创伤后应激障碍的神经调节疗法
Fed Pract. 2017 Mar;34(Suppl 2):20S-33S.
2
Neuromodulation for movement disorders.神经调节治疗运动障碍。
Neurosurg Clin N Am. 2014 Jan;25(1):47-58. doi: 10.1016/j.nec.2013.08.002. Epub 2013 Oct 8.
3
Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial.双侧丘脑深部脑刺激治疗难治性多发性硬化震颤的安全性和有效性:单中心、随机、单盲、初步试验。
Lancet Neurol. 2017 Sep;16(9):691-700. doi: 10.1016/S1474-4422(17)30166-7. Epub 2017 Jun 20.
4
Emerging applications of deep brain stimulation.深部脑刺激的新兴应用。
J Neurosurg Sci. 2016 Jun;60(2):242-55. Epub 2016 Jan 20.
5
One Pass Thalamic and Subthalamic Stimulation for Patients with Tremor-Dominant Idiopathic Parkinson Syndrome (OPINION): Protocol for a Randomized, Active-Controlled, Double-Blinded Pilot Trial.单通道丘脑和丘脑底核刺激治疗震颤为主型特发性帕金森综合征患者(OPINION):一项随机、活性对照、双盲试点试验的方案
JMIR Res Protoc. 2018 Jan 30;7(1):e36. doi: 10.2196/resprot.8341.
6
Developing a Deep Brain Stimulation Neuromodulation Network for Parkinson Disease, Essential Tremor, and Dystonia: Report of a Quality Improvement Project.开发用于帕金森病、特发性震颤和肌张力障碍的脑深部电刺激神经调节网络:一项质量改进项目报告
PLoS One. 2016 Oct 6;11(10):e0164154. doi: 10.1371/journal.pone.0164154. eCollection 2016.
7
Neuroimaging of Deep Brain Stimulation.深部脑刺激的神经影像学
Neurol Clin. 2020 Feb;38(1):201-214. doi: 10.1016/j.ncl.2019.09.005.
8
Chronic electrocorticography for sensing movement intention and closed-loop deep brain stimulation with wearable sensors in an essential tremor patient.慢性皮层电图用于感知运动意图,并通过可穿戴传感器对震颤患者进行闭环深脑刺激。
J Neurosurg. 2017 Sep;127(3):580-587. doi: 10.3171/2016.8.JNS16536. Epub 2016 Nov 18.
9
Effects of cerebellar neuromodulation in movement disorders: A systematic review.小脑神经调节对运动障碍的影响:系统评价。
Brain Stimul. 2018 Mar-Apr;11(2):249-260. doi: 10.1016/j.brs.2017.11.015. Epub 2017 Nov 23.
10
Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.对适合进行深部脑刺激的帕金森病患者进行丘脑底核谷氨酸脱羧酶基因转移。
Hum Gene Ther. 2001 Aug 10;12(12):1589-91.

引用本文的文献

1
Post-traumatic stress disorder: a psychiatric disorder requiring urgent attention.创伤后应激障碍:一种需要紧急关注的精神障碍。
Med Rev (2021). 2022 Aug 2;2(3):219-243. doi: 10.1515/mr-2022-0012. eCollection 2022 Jun.

本文引用的文献

1
Deep Brain Stimulation of the Basolateral Amygdala: Targeting Technique and Electrodiagnostic Findings.基底外侧杏仁核的深部脑刺激:靶向技术和电诊断发现。
Brain Sci. 2016 Aug 10;6(3):28. doi: 10.3390/brainsci6030028.
2
State of the Art for Deep Brain Stimulation Therapy in Movement Disorders: A Clinical and Technological Perspective.深部脑刺激疗法在运动障碍中的最新技术:临床与技术视角。
IEEE Rev Biomed Eng. 2016;9:219-33. doi: 10.1109/RBME.2016.2588399. Epub 2016 Jul 7.
3
Deep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Treatment-Resistant Depression: A Randomized Clinical Trial.深部脑刺激腹侧前肢内囊治疗抵抗性抑郁症的随机临床试验。
JAMA Psychiatry. 2016 May 1;73(5):456-64. doi: 10.1001/jamapsychiatry.2016.0152.
4
Association of Resting Metabolism in the Fear Neural Network With Extinction Recall Activations and Clinical Measures in Trauma-Exposed Individuals.恐惧神经网络静息代谢与创伤暴露个体中消退记忆激活及临床指标的相关性。
Am J Psychiatry. 2016 Sep 1;173(9):930-8. doi: 10.1176/appi.ajp.2015.14111460. Epub 2016 Feb 26.
5
Treatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future.治疗抵抗性创伤后应激障碍(TRPTSD):综述与未来框架。
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Oct 3;70:170-218. doi: 10.1016/j.pnpbp.2016.01.015. Epub 2016 Feb 6.
6
Deep Brain Stimulation for Movement Disorders.用于运动障碍的深部脑刺激
Nurs Clin North Am. 2015 Dec;50(4):691-701. doi: 10.1016/j.cnur.2015.07.014.
7
Deep Brain Stimulation of the Basolateral Amygdala for Treatment-Refractory Posttraumatic Stress Disorder.基底外侧杏仁核的深部脑刺激治疗难治性创伤后应激障碍
Biol Psychiatry. 2016 May 15;79(10):e82-e84. doi: 10.1016/j.biopsych.2015.09.003. Epub 2015 Sep 11.
8
Psychotherapy for Military-Related PTSD: A Review of Randomized Clinical Trials.军事相关 PTSD 的心理治疗:随机临床试验综述。
JAMA. 2015 Aug 4;314(5):489-500. doi: 10.1001/jama.2015.8370.
9
A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression.一项随机假手术对照试验:慢性难治性抑郁症患者的腹侧被盖区/腹侧纹状体深部脑刺激治疗。
Biol Psychiatry. 2015 Aug 15;78(4):240-8. doi: 10.1016/j.biopsych.2014.11.023. Epub 2014 Dec 13.
10
Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy.丘脑刺激术治疗药物难治性部分性癫痫的长期疗效及安全性
Neurology. 2015 Mar 10;84(10):1017-25. doi: 10.1212/WNL.0000000000001334. Epub 2015 Feb 6.

用于治疗难治性创伤后应激障碍的神经调节疗法

Neuromodulation for Treatment-Refractory PTSD.

作者信息

Langevin Jean-Philippe, Koek Ralph J, Schwartz Holly N, Chen James W Y, Sultzer David L, Mandelkern Mark A, Kulick Alexis D, Krahl Scott E

机构信息

is a neurosurgeon, is a neurologist, is a radiologist, and is a neurophysiologist in the research and development service; and are mental/behavioral health physicians, is a psychologist, and is a mental/behavioral health physician in the psychiatry and mental health service; all at the VA Greater Los Angeles Healthcare System in California. Dr. Langevin, Dr. Koek, Dr. Chen, Dr. Sultzer, Dr. Mandelkern, and Dr. Krahl are professors at David Geffen School of Medicine at the University of California Los Angeles.

出版信息

Fed Pract. 2017 Mar;34(Suppl 2):20S-33S.

PMID:30766304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6375501/
Abstract

Deep brain stimulation has been successful in treating Parkinson disease and essential tremor and is now reducing PTSD symptoms in the first patient enrolled in an early-phase safety trial.

摘要

深部脑刺激已成功用于治疗帕金森病和特发性震颤,目前在首例参与早期安全性试验的患者中,该疗法正在减轻创伤后应激障碍(PTSD)症状。